Ftse Mib
34.650,95
0,91%
DAX
18.772,85
0,50%
S&P 500
5.214,36
0,01%
NASDAQ
16.300,71
-0,28%
Bitcoin
60.763,65
-3,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Arena Pharmaceuticals Inc (ARNA) Arena Pharmaceuticals Inc (ARNA) Notizie

ARNA

Arena Pharmaceuticals (ARNA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARNA
DataOraFonteTitoloSimboloCompagnia
16/03/202211:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202222:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202220:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202215:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202215:05Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202215:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202214:59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
10/03/202212:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARNAArena Pharmaceuticals Inc
23/02/202223:00Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARNAArena Pharmaceuticals Inc
23/02/202222:05Business WireArena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program UpdatesNASDAQ:ARNAArena Pharmaceuticals Inc
17/02/202222:05Business WireArena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ARNAArena Pharmaceuticals Inc
09/02/202222:05Business WireArena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23NASDAQ:ARNAArena Pharmaceuticals Inc
21/01/202222:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARNAArena Pharmaceuticals Inc
23/12/202123:26Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:ARNAArena Pharmaceuticals Inc
14/12/202113:31TipRanksLeerink Partners Downgrades Arena Pharma (ARNA) to HoldNASDAQ:ARNAArena Pharmaceuticals Inc
14/12/202113:30TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Arena Pharma (ARNA), Global Blood Therapeutics (GBT) and Allogene Therapeutics (ALLO)NASDAQ:ARNAArena Pharmaceuticals Inc
14/12/202110:14TipRanksArena Pharmaceuticals Soars 80.4% on Pfizer’s $6.7B Acquisition DealNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202119:57Dow Jones NewsPfizer Shares Climb 5% Following Deal to Acquire Arena PharmaceuticalsNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202118:44Dow Jones NewsPfizer Deploying Some of Its Covid Cash in Arena Deal -- AnalysisNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202117:45TipRanksAnalyst Explains Why They Downgraded Their Rating on Arena Pharma (ARNA)NASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202116:44Dow Jones NewsArena Pharmaceuticals Shares Surge on Takeover by PfizerNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202112:56Dow Jones NewsPfizer to Buy Arena Pharmaceuticals at $6.7 Billion ValueNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202112:45Business WirePfizer to Acquire Arena PharmaceuticalsNASDAQ:ARNAArena Pharmaceuticals Inc
01/12/202110:06TipRanksLeerink Partners Maintains Their Buy Rating on Arena Pharma (ARNA)NASDAQ:ARNAArena Pharmaceuticals Inc
19/11/202114:30Business WireArena Pharmaceuticals Achieves Target Enrollment for Etrasimod CULTIVATE Study ANASDAQ:ARNAArena Pharmaceuticals Inc
04/11/202121:05Business WireArena Reports Third Quarter Financial Results and Key Program UpdatesNASDAQ:ARNAArena Pharmaceuticals Inc
14/10/202122:05Business WireArena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4NASDAQ:ARNAArena Pharmaceuticals Inc
02/09/202114:30Business WireArena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor ConferencesNASDAQ:ARNAArena Pharmaceuticals Inc
05/08/202122:05Business WireArena Reports Second Quarter Financial Results and Key Program UpdatesNASDAQ:ARNAArena Pharmaceuticals Inc
05/08/202113:00PR Newswire (US)Second Genome Announces Collaboration with Arena Pharmaceuticals to Identify Gastrointestinal BiomarkersNASDAQ:ARNAArena Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARNA

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network